How we are governed

Professional Advisory Board

Our Professional Advisory Board is a specifically appointed group of leading oncology professionals who offer independent advice on the quality and delivery of Maggie’s programme of cancer support.

  • Dr. Sam Guglani

    Consultant Clinical Oncologist
    Accordian open icon Accordian closed icon
  • Dr Andy Haynes

    Consultant Haematologist
    Accordian open icon Accordian closed icon
  • Dr James MacKay

    Consultant Clinical Genetic Oncologist
    Accordian open icon Accordian closed icon

Dr. Sam Guglani

Consultant Clinical Oncologist

Dr Sam Guglani is a Consultant Clinical Oncologist and curator of Medicine Unboxed. He qualified in Medicine at University College Hospital London Medical School in June 1995, also completing a BSc in Neuroscience there. He undertook training in general medical at Frenchay Hospital in Bristol and subsequently proceeded to specialist registrar training in Clinical Oncology in Bristol and Cheltenham, completing in 2005.

Following this, he spent a year as a Clinical and Research fellow at the Peter MacCallum Cancer institute in Melbourne, Australia prior to taking up a substantive Consultant post in Cheltenham as a Clinical Oncologist in March 2006.

His clinical duties are shared between Cheltenham General Hospital and Hereford County Hospital; he specialises in the treatment of patients with breast, lung and brain cancers. He also has an academic interest in clinical ethics and sits on the hospital Clinical Ethics Committee.

Dr Andy Haynes

Consultant Haematologist

Andy Haynes trained in Cambridge and London, completing his general medical training in Nottingham and specialist training in Edinburgh.

Andy returned to Nottingham as a lecturer and was appointed as a Leukaemia Research Fund senior lecturer in 1996. His main clinical interest is the management of lymphoma and he has been a principal investigator in national clinical trials.

He established the now nationally recognised molecular diagnostics laboratory service, providing vital support for the diagnosis and management of haematological cancers. In 2000 he became lead clinician for cancer, steering the City Hospital through two successful rounds of peer review. In 2007 he became the pathway lead clinician for unscheduled care.

Andy runs a research team with an interest in treatment resistance mechanisms in lymphoma, has published numerous papers and book chapters and is a reviewer for several journals. He is on the national medical advisory board for the Maggie's charity, the medical panel for the Lymphoma Association and the national and international advisory board of Roche and he is a member of the clinical trials committee for the Leukaemia Research Fund, for whom he has also written patient information.

Outside work Andy coaches the Nottinghamshire U11 county cricket team and an U19 academy football team. He also enjoys cooking and family life.

Dr James MacKay

Consultant Clinical Genetic Oncologist

Dr James Mackay is the only accredited Consultant Clinical Genetic Oncologist with a special interest in cancer genetics in the UK and is an honorary senior lecturer in the Department of Biology, University College London.  His clinical interests are cancer genetics, inherited cancer, cancer screening and the introduction of complex genetic tests into clinical cancer care.

Dr Mackay established regional cancer genetics services in East Anglia and North East Thames and developed a remote cancer genetics service, using real time tele-conferencing technology, based in Great Ormond Street Hospital NHS Trust. He holds honorary consultant contracts at several large London teaching hospitals.
 
He is the clinical principal investigator of an evaluation of regular mammography in women under 50 with a family history of breast cancer funded by the NHS Research and Development Programme. He initiated the Genetic Breast Cancer Trial, which is a trial of chemotherapy in women with breast cancer, who carry a faulty breast cancer gene - the first ever randomised trial of chemotherapy based on inherited genetic make-up

  • Mr Hamish Laing

    Consultant Plastic and Reconstructive Surgeon
    Accordian open icon Accordian closed icon
  • Prof. Jonathon Gray

    Director, Ko Awatea
    Accordian open icon Accordian closed icon
  • Prof. Sam Ahmedzai

    Professor of Palliative Medicine
    Accordian open icon Accordian closed icon

Mr Hamish Laing

Consultant Plastic and Reconstructive Surgeon

Mr Hamish Laing is a Consultant Plastic and Reconstructive Surgeon at the Welsh Centre for Burns and Plastic Surgery, and is based in Swansea. He is also a visiting Consultant to Cardiff & Vale and Gwent NHS Trusts.

Qualifying from King’s College Hospital in 1984, Hamish gained experience in a variety of surgical units and specialties, including the Royal Marsden and Great Ormond Street Hospitals, as a preliminary to specialising in Plastic and Reconstructive Surgery. He was awarded a first class BSc in Physiology and MB BS from University of London. A fellow of the Royal College of Surgeons of England, he holds the inter-collegiate FRCS in Plastic Surgery, FRCS (Plast).

Mr Laing holds the positions of the Lead for Sarcoma mdt in Morrison Hospital and is the Director of Acute Care for NHS. He is associated with BAPRAS.

Prof. Jonathon Gray

Director, Ko Awatea

Jonathon is the Chair and Director of the National Institute for Innovation and Improvement in at Auckland University in New Zealand, as well as the Director of the Centre for Health Services Innovation and Improvement at Counties Manukau District Health Board. Prior to this, he held the role of Consultant and Senior Lecturer in medical genetics at Cardiff and Vale NHS Trust where he worked on the 1000 Lives Campaign.

Jonathon believes that small changes are extremely important to quality improvement, especially when they lead to positive results, as it provides a good foundation to build further change.

Jonathon is a medical graduate from Dundee University, he is an accredited specialist in Clinical Genetics, and also in Public Health, with experience as a clinical director of a national specialist service, and a Director of Healthcare improvement in a national public health service.

Prof. Sam Ahmedzai

Professor of Palliative Medicine

Professor Admedzai is Chair and head of the Academic Unit of Supportive Care in the University of Sheffield.  He is an honorary consultant physician in palliative medicine, working in a hospital supportive care team and lead clinician for supportive and palliative care in the North Trent Cancer Network. Sam also heads the Sheffield Adult Cancer Survivorship project.

He is editor-in-chief of the Oxford University Press series on supportive care: `Current Opinion in Supportive and Palliative Care´ and of the section on supportive and palliative care for `BMJ Clinical Evidence´; he is also the clinical lead for the NHS Evidence Specialist Collection for Supportive and Palliative Care.

Sam is the Head of the Task Force on guideline for cancer pain for the International Association for Study of Pain. He also sits as a member on the Council of the British Pain Society; the Council of British Thoracic Oncology Group; the Circulatory and Respiratory Policy Group of National Council forPalliative Care; the Advisory Group for Department of Health on National Service Framework for COPD; the Nutrition Group for Help the Hospices; the Intercollegiate Cancer Committee on Multidisciplinary Team Working in Cancer; the Advisory Group of National Oesophago-Gastric Cancer Audit of Royal College of Radiologists.

  • Prof. Christopher Poole

    Professor of Medical Oncology
    Accordian open icon Accordian closed icon
  • Prof. Robert Leonard

    Professor in Medical Oncology
    Accordian open icon Accordian closed icon
  • Dr Noelle O’Rourke

    Consultant in Clinical Oncology
    Accordian open icon Accordian closed icon

Prof. Christopher Poole

Professor of Medical Oncology

Professor Christopher Poole holds the Chair of Medical Oncology at the University of Warwick, UK, and is Honorary Consultant Medical Oncologist to University Hospital Coventry and Warwickshire.

He qualified in Medicine from Cambridge University following pre-clinical studies at Sidney Sussex College and clinical training at Kings' College Hospital, London. After postgraduate training in general internal medicine at St George's, the Royal Marsden, and the St Thomas' Medical Registrar Rotation, he took an ICRF Clinical Research Fellowship at St Bartholomew's Hospital and completed his clinical training in Medical Oncology as a specialist registrar in Glasgow, and as Honorary Senior Registrar at Birmingham University Hospitals, whilst working as CRC Senior Clinical Research Fellow at the Trials Unit at the Institute for Cancer Studies. From 1994-2008 He was a Senior Lecturer in Medical Oncology at the University of Birmingham, developing major interests in the development of more effective systemic therapies for women with Breast and Gynaecological Cancer.

He sits on several national and international phase III trial Steering Committees, Trial Management Groups and Data and Safety Monitoring Committees. He is joint Principal Investigator of both the 2000-patient UK National Epirubicin Adjuvant Trial (NEAT), tAnGo, a 3000-patient trial of gemcitabine in anthracycline - based, paclitaxel - containing adjuvant chemotherapy for women with early stage breast cancer, and NeoEscape, a large randomised feasibility/phase II study of novel neo-adjuvant chemotherapy for women presenting with advanced inoperable Ovarian Cancer. He has sat on the NCRI Gynaecologial Cancer Studies Group and, as Clinical Lead for Research, launched the pan-Birmingham Cancer Research Network. He was until recently a member of CTAAC, CR-UK's Clinical Trial Advisory and Awards Committee, and is presently a member of the NCRI Breast Cancer Studies Group.

Prof. Robert Leonard

Professor in Medical Oncology

Professor Leonard originally trained and qualified at Charing Cross Hospital, where he was awarded the Clinical Gold Medal and six of the final year prizes. Research Fellowships at Oxford’s Radcliffe Infirmary and Harvard Medical School followed his post-graduate training. Prior to his current roles as Professor of Cancer Studies and Chief of Service for Medical Oncology at Imperial College, he was Professor of Medical Oncology at Swansea Medical School and Director of the South West Wales Cancer Institute.

He has authored or co-authored over 300 peer-reviewed papers, sits on six editorial boards, and is a member of over ten research groups, many of which have a particular focus on breast cancer.  Professor Leonard is a Medical Director of the cancer care charity, Maggie’s Cancer Caring Centres.

Dr Noelle O’Rourke

Consultant in Clinical Oncology

Noelle is a Consultant in Clinical Oncology and Honorary Senior Lecturer in Glasgow, specialising in the management of lung cancer, mesothelioma and haematological malignancies. She trained in oncology in Oxford and at the Hammersmith Hospital in London and has been in Glasgow since 1996. As well as a busy clinical practice, she is active in clinical research and education and is currently the elected Chair of the Beatson Consultants’ Committee.

Noelle is also a Non Exec Director on the Board of Beatson Cancer Charity.

  • Dr Chris Alcock

    Consultant in Clinical Oncology
    Accordian open icon Accordian closed icon
  • Lynne Dodson

    Lead Cancer Nurse
    Accordian open icon Accordian closed icon
  • Dr Agusti Barnadas

    Chief of Medical Oncology
    Accordian open icon Accordian closed icon

Dr Chris Alcock

Consultant in Clinical Oncology

Chris Alcock is a consultant in Clinical Oncology at the Oxford University Hospitals.  He has been Clinical Director of his department, Cancer Lead Clinician for the Trust, and as Chair of the PFI Steering Group helped plan the new Oxford Cancer Centre, which opened in 2009.

His main clinical area of interest is head and neck cancer. Apart from working in Oxford, he was involved for many years in regular clinics at Stoke Mandeville Hospital where he helped develop a purpose built Cancer Care and Haematology Unit. 

His interest in cancer information spans two and a half decades and has included the production of a radiotherapy video in the early 1980’s, followed by departmental information leaflets and chairing the group responsible for the original Teamwork Cancer Information File in 2000. 

In 1994 he raised funds for and helped design the Abernethy Cancer Information Centre in Oxford and continues to support the production of and dissemination of cancer information within Oxford Radcliffe Hospitals.  He has served on the National Cancer Information Advisory Group.

In 2011 he was appointed to the part time post of Clinical Lead for NHS Evidence, under the auspices of the National Institute for Health & Clinical Evidence, helping promote evidence based medicine and produce Evidence Updates on a range of topics.

He is Clinical Lead for the NHS Evidence website for Health Professionals; co-creator of the CancerLinks website, providing information for cancer patients 

Lynne Dodson

Lead Cancer Nurse

Lynne is Lead Nurse at Southampton. She was previously Macmillan Lead Cancer Nurse, University Hospital Birmingham 

Dr Agusti Barnadas

Chief of Medical Oncology

Chief of Medical Oncology at the Hospital Santa Creu i Sant Pau since 2004.  He graduated in Medicine from the Autonomous University of Barcelona (UAB) in 1981 where he is also currently Associate Professor of Medicine, and also holds a PhD from Barcelona University.  He received his Oncology training at the Hospital Sant Pau and received further training in the Breast Cancer Service of Memorial Sloan-Kettering in New York.  He worked as Attending Physician in the Medical Oncology Dept of the Germans Trias i Pujol Hospital for six years until he was nominated Deputy Director of the Medical Oncology Department of the Institut Català d’Oncologia (ICO) at the same hospital.  Dr Barnadas specialises in the treatment of breast cancer and head and neck tumours.  A founder member of the GEICAM group, he is Vice-president and a member of the Board of Directors.  He is also General Secretary of the Board of the Spanish Society for Medical Oncology (SEOM).  He has been involved in more than 60 clinical trials and is author or co-author of more than 100 publications, collaborating with various international journals.  

  • Prof. Alistair Munro

    Professor of Radiation Oncology
    Accordian open icon Accordian closed icon
  • Prof. EK Yeoh

    Professor of Public Health
    Accordian open icon Accordian closed icon
  • Dr Mark Glaser

    Consultant in radiotherapy and oncology
    Accordian open icon Accordian closed icon

Prof. Alistair Munro

Professor of Radiation Oncology

Professor Alastair Munro originally trained at the University of St Andrews, graduating in 1972 with a BSc Medical Science, Hons (Anatomy), before going on to obtain his MBChB at the University of Dundee in 1975 and subsequent MRCP, FRCR and FRCP(E) throughout his career.

Alistair’s career began in London as Consultant Radiotherapist and Hon. Senior Lecturer at Hammersmith Hospital (1981-1988) but he then moved to Toronto for 3 years, working as a Staff Radiation Oncologist, before returning to London as a Consultant Radiotherapist for St Barts and the Royal London Hospital between 1991-1997.

In 1997 Professor Munro moved back to Dundee, taking up his post as Professor of Radiation Oncology and Honorary Consultant Radiotherapist, Ninewells Hospital and Medical School, where he is still based.

Some titles published by Professor Munro include Adjuvant radiotherapy in operable rectal cancer: A systematic review (2002) and  Challenges to Radiation Therapy (2003)

Prof. EK Yeoh

Professor of Public Health

Professor Yeoh studied medicine at the University of Hong Kong where he was elected President of the Student Union in 1969 and graduated in 1971. He specialised in gastroenterology. In 1979, he became a consultant physician at Queen Elizabeth Hospital.

After a 19-year career at Hong Kong government hospitals, with recognised work in AIDS research, Yeoh became the first Chief Executive of the newly formed Hospital Authority in 1990. In January 1999, He was appointed to the post of Secretary for Health and Welfare (a civil servant position). In 2002, he was appointed as the Secretary for Health, Welfare and Food under the new political appointee system.

Yeoh is currently a professor at The Jockey Club School of Public Health and Primary Care at the Chinese University of Hong Kong.

Dr Mark Glaser

Consultant in radiotherapy and oncology

Dr Mark Glaser has been a consultant in radiotherapy and oncology at Charing Cross Hospital since 1980 and an honorary consultant radiotherapist Hammersmith Hospital and Postgraduate Medical School since 1980. From 1981 he has been a clinical teacher at the University of London.  He was appointed as Clinical Director of Riverside HA Cancer Services in 1990; and in 1994 he became Director of the Departments of Radiotherapy at Hammersmith and Charing Cross Hospitals.

He was awarded a visiting professorship at Yale University in 1984 and has authored several of papers on cancer and radiation therapy.

Dr. Sam Guglani

Consultant Clinical Oncologist
Accordian open icon Accordian closed icon

Dr Sam Guglani is a Consultant Clinical Oncologist and curator of Medicine Unboxed. He qualified in Medicine at University College Hospital London Medical School in June 1995, also completing a BSc in Neuroscience there. He undertook training in general medical at Frenchay Hospital in Bristol and subsequently proceeded to specialist registrar training in Clinical Oncology in Bristol and Cheltenham, completing in 2005.

Following this, he spent a year as a Clinical and Research fellow at the Peter MacCallum Cancer institute in Melbourne, Australia prior to taking up a substantive Consultant post in Cheltenham as a Clinical Oncologist in March 2006.

His clinical duties are shared between Cheltenham General Hospital and Hereford County Hospital; he specialises in the treatment of patients with breast, lung and brain cancers. He also has an academic interest in clinical ethics and sits on the hospital Clinical Ethics Committee.

Dr Andy Haynes

Consultant Haematologist
Accordian open icon Accordian closed icon

Andy Haynes trained in Cambridge and London, completing his general medical training in Nottingham and specialist training in Edinburgh.

Andy returned to Nottingham as a lecturer and was appointed as a Leukaemia Research Fund senior lecturer in 1996. His main clinical interest is the management of lymphoma and he has been a principal investigator in national clinical trials.

He established the now nationally recognised molecular diagnostics laboratory service, providing vital support for the diagnosis and management of haematological cancers. In 2000 he became lead clinician for cancer, steering the City Hospital through two successful rounds of peer review. In 2007 he became the pathway lead clinician for unscheduled care.

Andy runs a research team with an interest in treatment resistance mechanisms in lymphoma, has published numerous papers and book chapters and is a reviewer for several journals. He is on the national medical advisory board for the Maggie's charity, the medical panel for the Lymphoma Association and the national and international advisory board of Roche and he is a member of the clinical trials committee for the Leukaemia Research Fund, for whom he has also written patient information.

Outside work Andy coaches the Nottinghamshire U11 county cricket team and an U19 academy football team. He also enjoys cooking and family life.

Dr James MacKay

Consultant Clinical Genetic Oncologist
Accordian open icon Accordian closed icon

Dr James Mackay is the only accredited Consultant Clinical Genetic Oncologist with a special interest in cancer genetics in the UK and is an honorary senior lecturer in the Department of Biology, University College London.  His clinical interests are cancer genetics, inherited cancer, cancer screening and the introduction of complex genetic tests into clinical cancer care.

Dr Mackay established regional cancer genetics services in East Anglia and North East Thames and developed a remote cancer genetics service, using real time tele-conferencing technology, based in Great Ormond Street Hospital NHS Trust. He holds honorary consultant contracts at several large London teaching hospitals.
 
He is the clinical principal investigator of an evaluation of regular mammography in women under 50 with a family history of breast cancer funded by the NHS Research and Development Programme. He initiated the Genetic Breast Cancer Trial, which is a trial of chemotherapy in women with breast cancer, who carry a faulty breast cancer gene - the first ever randomised trial of chemotherapy based on inherited genetic make-up

Mr Hamish Laing

Consultant Plastic and Reconstructive Surgeon
Accordian open icon Accordian closed icon

Mr Hamish Laing is a Consultant Plastic and Reconstructive Surgeon at the Welsh Centre for Burns and Plastic Surgery, and is based in Swansea. He is also a visiting Consultant to Cardiff & Vale and Gwent NHS Trusts.

Qualifying from King’s College Hospital in 1984, Hamish gained experience in a variety of surgical units and specialties, including the Royal Marsden and Great Ormond Street Hospitals, as a preliminary to specialising in Plastic and Reconstructive Surgery. He was awarded a first class BSc in Physiology and MB BS from University of London. A fellow of the Royal College of Surgeons of England, he holds the inter-collegiate FRCS in Plastic Surgery, FRCS (Plast).

Mr Laing holds the positions of the Lead for Sarcoma mdt in Morrison Hospital and is the Director of Acute Care for NHS. He is associated with BAPRAS.

Prof. Jonathon Gray

Director, Ko Awatea
Accordian open icon Accordian closed icon

Jonathon is the Chair and Director of the National Institute for Innovation and Improvement in at Auckland University in New Zealand, as well as the Director of the Centre for Health Services Innovation and Improvement at Counties Manukau District Health Board. Prior to this, he held the role of Consultant and Senior Lecturer in medical genetics at Cardiff and Vale NHS Trust where he worked on the 1000 Lives Campaign.

Jonathon believes that small changes are extremely important to quality improvement, especially when they lead to positive results, as it provides a good foundation to build further change.

Jonathon is a medical graduate from Dundee University, he is an accredited specialist in Clinical Genetics, and also in Public Health, with experience as a clinical director of a national specialist service, and a Director of Healthcare improvement in a national public health service.

Prof. Sam Ahmedzai

Professor of Palliative Medicine
Accordian open icon Accordian closed icon

Professor Admedzai is Chair and head of the Academic Unit of Supportive Care in the University of Sheffield.  He is an honorary consultant physician in palliative medicine, working in a hospital supportive care team and lead clinician for supportive and palliative care in the North Trent Cancer Network. Sam also heads the Sheffield Adult Cancer Survivorship project.

He is editor-in-chief of the Oxford University Press series on supportive care: `Current Opinion in Supportive and Palliative Care´ and of the section on supportive and palliative care for `BMJ Clinical Evidence´; he is also the clinical lead for the NHS Evidence Specialist Collection for Supportive and Palliative Care.

Sam is the Head of the Task Force on guideline for cancer pain for the International Association for Study of Pain. He also sits as a member on the Council of the British Pain Society; the Council of British Thoracic Oncology Group; the Circulatory and Respiratory Policy Group of National Council forPalliative Care; the Advisory Group for Department of Health on National Service Framework for COPD; the Nutrition Group for Help the Hospices; the Intercollegiate Cancer Committee on Multidisciplinary Team Working in Cancer; the Advisory Group of National Oesophago-Gastric Cancer Audit of Royal College of Radiologists.

Prof. Christopher Poole

Professor of Medical Oncology
Accordian open icon Accordian closed icon

Professor Christopher Poole holds the Chair of Medical Oncology at the University of Warwick, UK, and is Honorary Consultant Medical Oncologist to University Hospital Coventry and Warwickshire.

He qualified in Medicine from Cambridge University following pre-clinical studies at Sidney Sussex College and clinical training at Kings' College Hospital, London. After postgraduate training in general internal medicine at St George's, the Royal Marsden, and the St Thomas' Medical Registrar Rotation, he took an ICRF Clinical Research Fellowship at St Bartholomew's Hospital and completed his clinical training in Medical Oncology as a specialist registrar in Glasgow, and as Honorary Senior Registrar at Birmingham University Hospitals, whilst working as CRC Senior Clinical Research Fellow at the Trials Unit at the Institute for Cancer Studies. From 1994-2008 He was a Senior Lecturer in Medical Oncology at the University of Birmingham, developing major interests in the development of more effective systemic therapies for women with Breast and Gynaecological Cancer.

He sits on several national and international phase III trial Steering Committees, Trial Management Groups and Data and Safety Monitoring Committees. He is joint Principal Investigator of both the 2000-patient UK National Epirubicin Adjuvant Trial (NEAT), tAnGo, a 3000-patient trial of gemcitabine in anthracycline - based, paclitaxel - containing adjuvant chemotherapy for women with early stage breast cancer, and NeoEscape, a large randomised feasibility/phase II study of novel neo-adjuvant chemotherapy for women presenting with advanced inoperable Ovarian Cancer. He has sat on the NCRI Gynaecologial Cancer Studies Group and, as Clinical Lead for Research, launched the pan-Birmingham Cancer Research Network. He was until recently a member of CTAAC, CR-UK's Clinical Trial Advisory and Awards Committee, and is presently a member of the NCRI Breast Cancer Studies Group.

Prof. Robert Leonard

Professor in Medical Oncology
Accordian open icon Accordian closed icon

Professor Leonard originally trained and qualified at Charing Cross Hospital, where he was awarded the Clinical Gold Medal and six of the final year prizes. Research Fellowships at Oxford’s Radcliffe Infirmary and Harvard Medical School followed his post-graduate training. Prior to his current roles as Professor of Cancer Studies and Chief of Service for Medical Oncology at Imperial College, he was Professor of Medical Oncology at Swansea Medical School and Director of the South West Wales Cancer Institute.

He has authored or co-authored over 300 peer-reviewed papers, sits on six editorial boards, and is a member of over ten research groups, many of which have a particular focus on breast cancer.  Professor Leonard is a Medical Director of the cancer care charity, Maggie’s Cancer Caring Centres.

Dr Noelle O’Rourke

Consultant in Clinical Oncology
Accordian open icon Accordian closed icon

Noelle is a Consultant in Clinical Oncology and Honorary Senior Lecturer in Glasgow, specialising in the management of lung cancer, mesothelioma and haematological malignancies. She trained in oncology in Oxford and at the Hammersmith Hospital in London and has been in Glasgow since 1996. As well as a busy clinical practice, she is active in clinical research and education and is currently the elected Chair of the Beatson Consultants’ Committee.

Noelle is also a Non Exec Director on the Board of Beatson Cancer Charity.

Dr Chris Alcock

Consultant in Clinical Oncology
Accordian open icon Accordian closed icon

Chris Alcock is a consultant in Clinical Oncology at the Oxford University Hospitals.  He has been Clinical Director of his department, Cancer Lead Clinician for the Trust, and as Chair of the PFI Steering Group helped plan the new Oxford Cancer Centre, which opened in 2009.

His main clinical area of interest is head and neck cancer. Apart from working in Oxford, he was involved for many years in regular clinics at Stoke Mandeville Hospital where he helped develop a purpose built Cancer Care and Haematology Unit. 

His interest in cancer information spans two and a half decades and has included the production of a radiotherapy video in the early 1980’s, followed by departmental information leaflets and chairing the group responsible for the original Teamwork Cancer Information File in 2000. 

In 1994 he raised funds for and helped design the Abernethy Cancer Information Centre in Oxford and continues to support the production of and dissemination of cancer information within Oxford Radcliffe Hospitals.  He has served on the National Cancer Information Advisory Group.

In 2011 he was appointed to the part time post of Clinical Lead for NHS Evidence, under the auspices of the National Institute for Health & Clinical Evidence, helping promote evidence based medicine and produce Evidence Updates on a range of topics.

He is Clinical Lead for the NHS Evidence website for Health Professionals; co-creator of the CancerLinks website, providing information for cancer patients 

Lynne Dodson

Lead Cancer Nurse
Accordian open icon Accordian closed icon

Lynne is Lead Nurse at Southampton. She was previously Macmillan Lead Cancer Nurse, University Hospital Birmingham 

Dr Agusti Barnadas

Chief of Medical Oncology
Accordian open icon Accordian closed icon

Chief of Medical Oncology at the Hospital Santa Creu i Sant Pau since 2004.  He graduated in Medicine from the Autonomous University of Barcelona (UAB) in 1981 where he is also currently Associate Professor of Medicine, and also holds a PhD from Barcelona University.  He received his Oncology training at the Hospital Sant Pau and received further training in the Breast Cancer Service of Memorial Sloan-Kettering in New York.  He worked as Attending Physician in the Medical Oncology Dept of the Germans Trias i Pujol Hospital for six years until he was nominated Deputy Director of the Medical Oncology Department of the Institut Català d’Oncologia (ICO) at the same hospital.  Dr Barnadas specialises in the treatment of breast cancer and head and neck tumours.  A founder member of the GEICAM group, he is Vice-president and a member of the Board of Directors.  He is also General Secretary of the Board of the Spanish Society for Medical Oncology (SEOM).  He has been involved in more than 60 clinical trials and is author or co-author of more than 100 publications, collaborating with various international journals.  

Prof. Alistair Munro

Professor of Radiation Oncology
Accordian open icon Accordian closed icon

Professor Alastair Munro originally trained at the University of St Andrews, graduating in 1972 with a BSc Medical Science, Hons (Anatomy), before going on to obtain his MBChB at the University of Dundee in 1975 and subsequent MRCP, FRCR and FRCP(E) throughout his career.

Alistair’s career began in London as Consultant Radiotherapist and Hon. Senior Lecturer at Hammersmith Hospital (1981-1988) but he then moved to Toronto for 3 years, working as a Staff Radiation Oncologist, before returning to London as a Consultant Radiotherapist for St Barts and the Royal London Hospital between 1991-1997.

In 1997 Professor Munro moved back to Dundee, taking up his post as Professor of Radiation Oncology and Honorary Consultant Radiotherapist, Ninewells Hospital and Medical School, where he is still based.

Some titles published by Professor Munro include Adjuvant radiotherapy in operable rectal cancer: A systematic review (2002) and  Challenges to Radiation Therapy (2003)

Prof. EK Yeoh

Professor of Public Health
Accordian open icon Accordian closed icon

Professor Yeoh studied medicine at the University of Hong Kong where he was elected President of the Student Union in 1969 and graduated in 1971. He specialised in gastroenterology. In 1979, he became a consultant physician at Queen Elizabeth Hospital.

After a 19-year career at Hong Kong government hospitals, with recognised work in AIDS research, Yeoh became the first Chief Executive of the newly formed Hospital Authority in 1990. In January 1999, He was appointed to the post of Secretary for Health and Welfare (a civil servant position). In 2002, he was appointed as the Secretary for Health, Welfare and Food under the new political appointee system.

Yeoh is currently a professor at The Jockey Club School of Public Health and Primary Care at the Chinese University of Hong Kong.

Dr Mark Glaser

Consultant in radiotherapy and oncology
Accordian open icon Accordian closed icon

Dr Mark Glaser has been a consultant in radiotherapy and oncology at Charing Cross Hospital since 1980 and an honorary consultant radiotherapist Hammersmith Hospital and Postgraduate Medical School since 1980. From 1981 he has been a clinical teacher at the University of London.  He was appointed as Clinical Director of Riverside HA Cancer Services in 1990; and in 1994 he became Director of the Departments of Radiotherapy at Hammersmith and Charing Cross Hospitals.

He was awarded a visiting professorship at Yale University in 1984 and has authored several of papers on cancer and radiation therapy.